V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10008413 | 10004986 | 1.7 | 91.4 | Palliative (P) | 2019-01-25 | 2019-02-06 | Sunitinib | N | N | 10506765 | CAPECITABINE + IRINOTECAN |
| 10008414 | 10004988 | 1.71 | 76.8 | Palliative (P) | null | 2016-09-11 | CETUXIMAB + IRINOTECAN + MDG | N | N | 10506788 | EOX |
| 10008415 | 10004989 | 1.66 | 75 | Curative (C) | 2015-10-02 | 2015-10-16 | CARBOPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | 10506951 | CETUXIMAB + RT |
| 10008416 | 10004989 | 1.79 | 95.5 | Palliative (P) | 2014-03-27 | 2014-03-27 | RUXOLITINIB | 02 | N | 10506951 | CRIZOTINIB |
| 10008417 | 10004989 | null | 64 | Curative (C) | 2015-08-27 | 2015-09-01 | Cetuximab + FOLFIRI cycle 2 onwards | 01 | N | 10506951 | TOPOTECAN |
| 10008418 | 10004991 | 1.53 | null | Curative (C) | 2013-10-31 | 2013-11-02 | EC | null | N | 10507266 | DOCETAXEL + TRASTUZUMAB |
| 10008419 | 10004994 | 1.57 | 70.6 | Palliative (P) | 2018-04-12 | 2018-06-29 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN | 02 | N | 10507380 | FCR |
| 10008420 | 10004999 | 1.7 | null | Palliative (P) | 2018-12-13 | 2019-01-10 | FLAIR Trial | N | N | 10508471 | ESHAP |
| 10008421 | 10005000 | 1.54 | 54.2 | Palliative (P) | 2018-02-10 | 2018-02-11 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 2 | N | 10508636 | CISPLATIN + PEMETREXED |
| 10008422 | 10005002 | null | 104 | Disease modification (D) | 2016-02-27 | 2016-02-27 | CETUXIMAB | N | N | 10508708 | CVD |
| 10008423 | 10005003 | null | 79 | Palliative (P) | 2017-07-06 | 2017-07-31 | Docetaxel + Nintedanib | 02 | Y | 10508761 | VENETOCLAX |
| 10008424 | 10005009 | 1.53 | 49.1 | Palliative (P) | 2017-03-16 | 2017-03-30 | Vinorelbine IV | 02 | N | 10509088 | CHOP |
| 10008425 | 10005010 | 1.72 | 131.2 | Palliative (P) | 2015-01-31 | 2015-05-25 | Irinotecan | 02 | null | 10509197 | IDARUBICIN |
| 10008426 | 10005013 | 1.84 | null | Curative (C) | 2016-10-16 | 2016-11-12 | IMATINIB | 99 | null | 10509302 | GDP |
| 10008427 | 10005016 | 1.58 | 0 | Curative (C) | 2015-11-15 | 2015-11-19 | Cyclophosphamide oral | N | N | 10509722 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 10008428 | 10005019 | 1.7 | 60.4 | Curative (C) | 2015-12-28 | 2016-03-08 | IMATINIB | 02 | null | 10509834 | CAP + RT |
| 10008429 | 10005021 | 1.8 | null | Palliative (P) | 2018-05-25 | 2018-07-05 | QUASAR 2 TRIAL | N | N | 10509858 | ENZALUTAMIDE |
| 10008430 | 10005023 | 1.62 | 51.5 | Disease modification (D) | 2016-01-16 | 2016-01-21 | Cetuximab + Radiotherapy Maint | N | N | 10510047 | CISPLATIN + PEMETREXED |
| 10008431 | 10005024 | null | 100 | Palliative (P) | 2015-10-22 | 2015-10-29 | CAP + RT | N | N | 10510063 | LEAM |
| 10008432 | 10005031 | 1.84 | 101.7 | Neo-adjuvant (N) | 2014-06-06 | 2014-08-12 | Bexarotene | N | N | 10511124 | CHOP |
| 10008433 | 10005033 | 1.7 | 94.7 | Palliative (P) | 2016-07-12 | 2016-07-21 | NEOBLADE trial | N | N | 10511258 | CHLORAMBUCIL |
| 10008434 | 10005034 | 1.65 | 93 | Palliative (P) | 2014-11-30 | 2014-12-01 | Cabazitaxel | N | N | 10511315 | NIVOLUMAB |
| 10008435 | 10005035 | null | 85 | Palliative (P) | 2017-04-06 | 2017-08-18 | Mitoxantrone | 2 | N | 10511670 | CAPECITABINE + GEMCITABINE |
| 10008436 | 10005040 | 1.7 | 76.9 | Palliative (P) | 2014-09-02 | 2015-01-14 | Cyclophosphamide oral | 2 | N | 10512345 | FLUOROURACIL + MITOMYCIN + RT |
| 10008437 | 10005043 | 1.74 | null | Palliative (P) | 2016-01-28 | 2016-02-26 | Irinotecan 14day | N | N | 10512604 | VINORELBINE |
| 10008438 | 10008597 | 1.79 | null | null | 2016-08-12 | 2016-08-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 10513745 | CHLORAMBUCIL |
| 10008439 | 10005049 | 1.75 | 75 | null | 2016-07-01 | 2016-07-17 | NIVOLUMAB | N | N | 10513915 | CHOP |
| 10008440 | 10005049 | null | 71 | Curative (C) | 2018-01-01 | 2018-01-15 | CARBOPLATIN + FLUOROURACIL | 2 | N | 10513915 | METHOTREXATE INTRATHECAL |
| 10008441 | 10005052 | 1.67 | 74 | Palliative (P) | 2018-03-08 | 2018-08-17 | CISPLATIN + GEMCITABINE | N | N | 10514463 | CVD |
| 10008442 | 10007534 | 1.71 | 80 | Palliative (P) | 2017-09-03 | 2017-09-04 | Chlorambucil + Pred + Rituximab | N | N | 10514513 | IVAC |
| 10008443 | 10005056 | 1.73 | null | Curative (C) | 2016-07-07 | 2016-07-08 | Erlotinib | N | N | 10514673 | CHLVPP/PABLOE |
| 10008444 | 10005060 | 1.84 | 0 | Not known (9) | 2016-07-10 | 2016-12-04 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10514873 | IPILIMUMAB + NIVOLUMAB |
| 10008445 | 10005061 | null | null | Palliative (P) | 2015-07-11 | 2015-07-21 | IMATINIB | 2 | null | 10514873 | CHOP R + METHOTREXATE |
| 10008446 | 10005062 | 1.75 | 62.8 | Palliative (P) | 2017-11-27 | 2017-12-06 | CYCLOPHOSPHAMIDE + RITUXIMAB | Y | N | 10515249 | CISPLATIN + FLUOROURACIL |
| 10008447 | 10005063 | 1.72 | 73.3 | Curative (C) | 2019-04-13 | 2019-04-29 | CYTARABINE + DAUNORUBICIN | N | N | 10515391 | CISPLATIN + GEMCITABINE |
| 10008448 | 10005064 | 1.71 | 80 | Palliative (P) | 2015-04-08 | 2015-04-27 | CAPECITABINE + IRINOTECAN | N | N | 10515420 | AXITINIB |
| 10008449 | 10005068 | null | 80 | Palliative (P) | 2018-09-04 | 2018-11-11 | CLARITY Trial | N | N | 10515574 | METHOTREXATE |
| 10008450 | 10005071 | 1.75 | 82.3 | Curative (C) | 2017-07-09 | 2018-07-04 | Melphalan IV High dose | 2 | N | 10516284 | CYTARABINE |
| 10008451 | 10005073 | 1.76 | 64.7 | Palliative (P) | 2018-04-01 | 2018-08-15 | Capecitabine + Cisplatin + RT | 02 | N | 10516739 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE |
| 10008452 | 10005075 | 1.67 | 74.6 | Palliative (P) | 2015-04-27 | 2015-05-23 | Cisplatin | 02 | N | 10516791 | CHLORAMBUCIL |
| 10008453 | 10005076 | 1.7 | 56.2 | null | 2014-04-01 | 2014-05-01 | Docetaxel + Nintedanib | 02 | N | 10516936 | IMATINIB |
| 10008454 | 10007543 | 1.7 | 109 | Palliative (P) | 2018-09-23 | 2019-02-17 | CAV | N | N | 10517435 | CETUXIMAB + IRINOTECAN + MDG |
| 10008455 | 10005081 | 1.8 | 112 | Adjuvant (A) | 2016-09-07 | 2016-09-07 | Cisplatin + Pemetrexed | N | N | 10517595 | CETUXIMAB |
| 10008456 | 10005083 | 1.66 | 51 | Palliative (P) | 2017-04-13 | 2017-04-13 | Cytarabine High Dose | N | N | 10517635 | MPV |
| 10008457 | 10005084 | 1.7 | 64.8 | Palliative (P) | 2017-08-07 | 2017-09-21 | Venetoclax | 2 | N | 10517854 | THALIDOMIDE |
| 10008458 | 10005085 | 1.84 | 91 | Palliative (P) | 2017-05-31 | 2017-07-03 | Mini BEAM | 02 | N | 10517995 | CETUXIMAB |
| 10008459 | 10005085 | 1.83 | 89.5 | Neo-adjuvant (N) | 2017-10-07 | 2017-10-12 | CISPLATIN + FLUOROURACIL | 02 | N | 10517995 | FLAG + IDARUBICIN |
| 10008460 | 10005086 | 1.7 | 80.6 | Palliative (P) | null | 2017-02-11 | Melphalan IV High dose | N | N | 10518314 | MYELOMA XI TRIAL |
| 10008461 | 10005087 | 1.73 | 77.8 | Palliative (P) | 2018-03-24 | 2018-04-22 | CISPLATIN + RT | N | N | 10519073 | CISPLATIN + FLUOROURACIL |
| 10008462 | 10005089 | 1.74 | 74 | Disease modification (D) | 2016-01-18 | 2016-01-21 | Vinorelbine IV | 02 | N | 10519110 | NINTEDANIB |